What are the recommended pyridoxine (vitamin B6) dosing regimens for adults, pregnant women, children, and for prevention of isoniazid‑induced peripheral neuropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pyridoxine (Vitamin B6) Dosing

Bold Recommendation: Give 25–50 mg/day pyridoxine with isoniazid to all patients at risk of neuropathy; increase to 100 mg/day if neuropathy develops 1, 2.

  • Adults (general nutrition; EN/PN):

    • Enteral nutrition: ≥1.5 mg/day when providing ~1500 kcal 3, 4.
    • Parenteral nutrition: 4–6 mg/day 3, 4.
  • Adults on isoniazid (INH) for TB:

    • Prophylaxis in at‑risk patients: 25–50 mg/day PO [1, Table note; 2].
    • If peripheral neuropathy occurs: 100 mg/day PO 1.
    • Rationale: Prevents INH‑induced neuropathy, preserving function/QOL and avoiding disability 1. Avoid chronic high doses (>100 mg/day) due to B6‑toxicity neuropathy risk 4.
  • Pregnant and breastfeeding patients on INH:

    • 25–50 mg/day PO (start with 25 mg/day; many programs use 50 mg/day) 1, 5, 2.
    • Note: Multivitamins alone usually provide <25 mg and are insufficient with INH 5.
    • Evidence nuance: Older data show 50–60 mg/day achieves adequate PLP during pregnancy on INH 6; guideline dosing above governs 1, 2.
  • Children on INH:

    • Give pyridoxine to at‑risk children (e.g., malnourished, HIV): commonly 1–2 mg/kg/day (practice standard); if neuropathy, up‑titrate toward 50–100 mg/day per clinical response while respecting safety limits. Guideline emphasis: provide B6 with INH in at‑risk children to prevent neuropathy and preserve neurodevelopment/QOL 1, 2, 7.
    • Note: Major adult guidelines specify risk‑based prophylaxis; pediatric specifics are less prescriptive—err on prevention in malnutrition/HIV 1, 2, 7.
  • Isoniazid overdose (toxicity/seizures):

    • Give IV pyridoxine gram‑for‑gram equal to INH ingested; if unknown amount: adults 5 g IV over 30–60 min; children 80 mg/kg IV (repeat if seizures persist; total often ≤10 g) 8. Supported by ESPEN “high‑dose in INH overdose” recommendation 3, 4.
  • Upper limits/toxicity (safety):

    • Chronic doses ≥100 mg/day have been associated with sensory neuropathy; avoid prolonged high dosing unless treating toxicity as above 4, 3.
    • FDA OTC products commonly list 50 mg/day for adults; follow TB guidelines when on INH 9, 1, 2.

Algorithm (prioritized by morbidity, mortality, QOL):

  1. On INH?
    • Yes + risk factors (pregnancy, breastfeeding infant, HIV, diabetes, alcoholism, malnutrition, CKD, advanced age): 25–50 mg/day; neuropathy → 100 mg/day 1, 2.
    • No risk factors: consider 25 mg/day if any concern; monitor symptoms.
  2. Not on INH, receiving EN/PN:
    • EN: ≥1.5 mg/day; PN: 4–6 mg/day 3, 4.
  3. INH overdose/seizures:
    • Treat immediately with IV pyridoxine per dose‑matched protocol (or 5 g adult/80 mg/kg child if unknown) 8.
  4. Avoid chronic >100 mg/day unless for acute toxicity management; reassess to prevent B6‑induced neuropathy 4.

Common pitfalls and how to avoid:

  • Relying on prenatal vitamins alone during INH therapy—add 25–50 mg/day pyridoxine 5.
  • Delayed escalation when neuropathy appears—increase to 100 mg/day promptly to protect function/QOL 1.
  • Prolonged high‑dose supplementation without indication—risk of B6‑induced neuropathy; keep ≤100 mg/day chronically 4.
  • Skipping pediatric prophylaxis in malnourished/HIV‑infected children on INH—provide B6 to prevent disability 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.